S. Schneeweiss

First name
S.
Last name
Schneeweiss
Pradhan, R., Patorno, E., Tesfaye, H., Schneeweiss, S., Yin, H., Franklin, J., et al. (2022). Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwac021
Tazare, J., Wyss, R., Franklin, J. M., Smeeth, L., Evans, S. J. W., Wang, S. V., et al. (2022). Transparency of high-dimensional propensity score analyses: guidance for diagnostics and reporting. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5412
Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., et al. (2018). Real-world effects of medications for chronic obstructive pulmonary disease: protocol for a UK population-based non-interventional cohort study with validation against randomised trial results. BMJ Open. http://doi.org/10.1136/bmjopen-2017-019475
Rassen, J. A., Bartels, D. B., Schneeweiss, S., Patrick, A. R., & Murk, W. (2019). Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases. Clin Epidemiol. http://doi.org/10.2147/clep.s181242
Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., et al. (2020). Real world effects of COPD medications: a cohort study with validation against RCT results. Eur Respir J. http://doi.org/10.1183/13993003.01586-2020
Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., et al. (2021). Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Health Technol Assess. http://doi.org/10.3310/hta25510
Suissa, K., Schneeweiss, S., Douros, A., Filion, K. B., Yin, H., Patorno, E., & Azoulay, L. (2021). The modifying effects of adiposity on the cardiovascular safety of sulphonylureas. Diabetes Obes Metab. http://doi.org/10.1111/dom.14494